NIH sole-source GloMax Discover System from Promega.
Some language patterns suggest this RFP may be written for a specific incumbent vendor. Review qualification requirements and brand-specific terms carefully before committing bid resources.
The National Institutes of Health (NIH) Clinical Center intends to award a sole-source contract to Promega Corporation for a GloMax Discover System and dual injectors with pumps. This system is used for bioluminescent and fluorescent assays in preclinical and clinical research. The requirement includes installation, training, and a one-year warranty. The NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing). The place of performance is Bethesda, Maryland. This is a special notice indicating a sole-source procurement, suggesting the equipment is proprietary and only available from Promega.